News & Analysis on Clinical Trial Services & Contract Research And Development
ChargePoint: acquisition by Arcline
By Jenni Spinner
- Last updated on
UK-based pharma equipment specialist ChargePoint Technologies has been acquired by Arcline Investment Management. The move reportedly will enable ChargePoint to accelerate its product development, in order to get products like sterile and contained process solutions to market more rapidly.
Chris Eccles, CEO of ChargePoint Technologies, said, “Partnering with Arcline is an incredible opportunity for us to further strengthen our commitment to delivering high-quality world class process solutions for our customers.”